Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sorbifer Plus is an oral iron and multivitamin combination product marketed by Multicare Pharmaceuticals (a subsidiary of Lupin). It is formulated to treat and prevent iron-deficiency anemia, particularly when accompanied by deficiencies in B-complex vitamins and folic acid. The product contains ferrous fumarate as a source of elemental iron, which is essential for the synthesis of hemoglobin and oxygen transport. It also includes folic acid and cyanocobalamin (Vitamin B12) to support erythropoiesis, along with thiamine (B1) and pyridoxine (B6) to support neurological health and energy metabolism. It is frequently utilized in prenatal care and for patients with chronic blood loss or nutritional malabsorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sorbifer Plus.